Bisio, M.; Legato, L.; Fasano, F.; Benevolo Savelli, C.; Boccomini, C.; Nicolosi, M.; Santambrogio, E.; Freilone, R.; Novo, M.; Botto, B.
Bispecific Antibodies for Lymphoid Malignancy Treatment. Cancers 2025, 17, 94.
https://doi.org/10.3390/cancers17010094
AMA Style
Bisio M, Legato L, Fasano F, Benevolo Savelli C, Boccomini C, Nicolosi M, Santambrogio E, Freilone R, Novo M, Botto B.
Bispecific Antibodies for Lymphoid Malignancy Treatment. Cancers. 2025; 17(1):94.
https://doi.org/10.3390/cancers17010094
Chicago/Turabian Style
Bisio, Matteo, Luca Legato, Filippo Fasano, Corrado Benevolo Savelli, Carola Boccomini, Maura Nicolosi, Elisa Santambrogio, Roberto Freilone, Mattia Novo, and Barbara Botto.
2025. "Bispecific Antibodies for Lymphoid Malignancy Treatment" Cancers 17, no. 1: 94.
https://doi.org/10.3390/cancers17010094
APA Style
Bisio, M., Legato, L., Fasano, F., Benevolo Savelli, C., Boccomini, C., Nicolosi, M., Santambrogio, E., Freilone, R., Novo, M., & Botto, B.
(2025). Bispecific Antibodies for Lymphoid Malignancy Treatment. Cancers, 17(1), 94.
https://doi.org/10.3390/cancers17010094
